The DPP-4 inhibitor-induced glomerular lesions we reported are similar to the glomerular lesions reported by Eremina et al. as VEGF inhibitor-induced thrombotic microangiopathy [9]. The gene discussed is VEGFA; the disease is thrombotic microangiopathy.